IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 227
EU - Europa 117
AS - Asia 53
AF - Africa 5
OC - Oceania 2
Totale 404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 223
IT - Italia 51
CN - Cina 24
DE - Germania 21
FI - Finlandia 13
SG - Singapore 13
IE - Irlanda 9
FR - Francia 8
IN - India 6
IR - Iran 5
CA - Canada 4
AE - Emirati Arabi Uniti 3
GB - Regno Unito 3
ZA - Sudafrica 3
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
SE - Svezia 2
AU - Australia 1
BE - Belgio 1
IQ - Iraq 1
KR - Corea 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 404
Salva come PNG Salva come JPEG
Città #
Boardman 57
New York 32
West Jordan 20
Los Angeles 14
Kitzingen 12
Shanghai 12
Ashburn 10
Chandler 10
Lappeenranta 8
L’Aquila 8
Dublin 7
Singapore 7
Bologna 5
Helsinki 5
Pontedera 5
Ravenna 5
Milan 4
Abu Dhabi 3
Pescara 3
Pretoria 3
Addis Ababa 2
Berlin 2
Brno 2
Columbus 2
Del Norte 2
Lambeth 2
Lucca 2
Matelica 2
Napa 2
Padova 2
Seriate 2
Stockholm 2
Toronto 2
Vallefoglia 2
Atlanta 1
Auckland 1
Baghdad 1
Bremen 1
Bucharest 1
Canberra 1
Des Moines 1
Dubendorf 1
Fermo 1
Florence 1
Frankfurt am Main 1
Gangbuk-gu 1
Hamburg 1
Las Vegas 1
Lawrence 1
Livorno 1
Montreal 1
Nanaimo 1
Naples 1
Nuremberg 1
Oslo 1
Phoenix 1
Piscataway 1
Princeton 1
Salt Lake City 1
San Mateo 1
Seattle 1
Sofia 1
Woodbridge 1
Zurich 1
Totale 288
Salva come PNG Salva come JPEG
Nome #
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 44
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 28
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 26
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 22
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 18
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 17
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 15
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 12
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 9
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 9
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 8
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 8
Endovascular Thrombectomy with or without Intravenous Thrombolysis for Anterior Circulation Large Vessel Occlusion in the Imperial College London Thrombectomy Registry 8
Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 8
Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome 8
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 7
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 7
Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases 7
Arthritic psoriasis during natalizumab treatment: a case report and review of the literature 7
Comparison of Drip‐and‐Ship Versus Mothership Delivery Models of Mechanical Thrombectomy Delivery 7
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 7
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 7
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 7
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 7
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable 6
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 6
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 6
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 6
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 6
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 6
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 6
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 6
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 6
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 6
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 6
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 6
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 6
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases 5
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 5
Guillain-Barré syndrome following COVID-19: new infection, old complication? 5
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve 5
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 5
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 5
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation 4
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 4
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 4
Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study 4
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 4
A 36-Year-Old Woman With Right Eye Ptosis 4
Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review 4
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium? 4
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 4
Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis 4
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 3
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 3
Left atrial appendage thrombosis in a patient with Friedreich Ataxia-related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation 3
Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome 3
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 3
Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease 3
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 3
Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation 3
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 3
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis 3
Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review 2
Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases 2
Outcomes of mechanical thrombectomy in orally anticoagulated patients with anterior circulation large vessel occlusion: a propensity-matched analysis of the Imperial College Thrombectomy Registry 2
Author Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 1
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 1
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases 1
Safety and outcomes of different endovascular treatment techniques for anterior circulation ischaemic stroke in the elderly: data from the Imperial College Thrombectomy Registry 1
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies 1
Totale 492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024389 6 10 16 47 22 47 3 3 3 80 63 89
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 492